DARE - Dare Bioscience, Inc.
2.91
-0.010 -0.344%
Share volume: 5,546
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$2.92
-0.01
0.00%
Summary score
31%
Profitability
25%
Dept financing
17%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-219.2%
Return on assets
-37.67%
Return on sales
0%
Return on invested capital
675.41%
Total debt ratio
36.56%
Debt ratio change over timeo
0%
Current Ratio
5.86%
Quick Ratio
0%
Cash Position Ratio
5.49%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-869.54%
Return on assets
-70.95%
Return on sales
0%
Return on invested capital
172.42%
Total debt ratio
72.76%
Debt ratio change over timeo
0%
Current Ratio
1.66%
Quick Ratio
0%
Cash Position Ratio
1.08%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-2288.87%
Return on assets
-83.14%
Return on sales
0%
Return on invested capital
134.66%
Total debt ratio
96.37%
Debt ratio change over time
0%
Current Ratio
1.28%
Quick Ratio
0%
Cash Position Ratio
0.88%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | DARE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -219.2% | 17.45% | 4.69% | 19.89% |
| Return on assets | -37.67% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 675.41% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 44% | 29% | 75% |
| Total debt ratio | 36.56% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 12% | 25% | 44% | 18% |
| Current Ratio | 1.66% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 1.08% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 27% | 35% | 22% |
| Short-term ratios | DARE | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -869.54% | 44.06% | 6.24% | 17.3% |
| Return on assets | -70.95% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 172.42% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 54% | 28% | 60% |
| Total debt ratio | 72.76% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 20% | 25% | 42% | 15% |
| Current Ratio | 1.66% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 1.08% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 43% | 56% | 42% |
